Regadenoson


- TRADE NAME: Lexiscan (Astellas)
- INDICATIONS: Radionuclide myocardial perfusion imaging
- CLASS: Adenosine A2A receptor agonist, Diagnostic aid
- HALF-LIFE: immediate: 30 minutes; terminal: 2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Caffeine, Dipyridamole, Theophylline
PREGNANCY CATEGORY: C
Contra-indicated in patients with second- or third-degree AV block or sinus node dysfunction.
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric